Nasdaq · CIK 0001850270
PROK PROKIDNEY CORP.
Insider trading from SEC Form 4. Last filing Mar 3, 2026. Close $1.74 on Oct 9, 2026, +31% from the 52-week low and -47% from the high.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
12
with a Form 4 at this company
Price and insider trades, last year
PROKOct 9, 2026 · close 1.74
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at PROKIDNEY CORP., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 60Notable | Brian JG Pereira director sell | $1.9M 757,162 shares | -112% | - | |
| 29Weak | Darin J. Weber Chief Regulatory Officer sell | $313k 103,480 shares | -100% | - | |
| 16Weak | Control Empresarial de Capitales S.A. de C.V. owner, other buy | $276k 387,393 shares | +1% | - | |
| 2Weak | Control Empresarial de Capitales S.A. de C.V. owner, other buy | $19k 25,000 shares | +0% | - | |
| 10Weak | Control Empresarial de Capitales S.A. de C.V. owner, other buy | $75k 100,000 shares | +0% | - | |
| 25Weak | Control Empresarial de Capitales S.A. de C.V. owner, other buy | $521k 736,105 shares | +1% | - | |
| 22Weak | Control Empresarial de Capitales S.A. de C.V. owner, other buy | $629k 1,034,118 shares | +1% | - |
Transactions
The last 30 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 1, 2026 | Bruce Culleton Chief Executive Officer | AGrant or award Employee stock option (right to buy)derivative | +3,000,000 | $0.00 | $0 | 3,000,000 | Mar 3, 2026 |
| Mar 1, 2026 | Todd C Girolamo Chief Legal Officer | AGrant or award Employee stock option (right to buy)derivative | +600,000 | $0.00 | $0 | 600,000 | Mar 3, 2026 |
| Mar 1, 2026 | Darin J. Weber Chief Regulatory Officer | AGrant or award Employee stock option (right to buy)derivative | +400,000 | $0.00 | $0 | 400,000 | Mar 3, 2026 |
| Mar 1, 2026 | James Coulston Chief Financial Officer | AGrant or award Employee stock option (right to buy)derivative | +600,000 | $0.00 | $0 | 600,000 | Mar 3, 2026 |
| Nov 12, 2025 | Brian JG Pereira director | SOpen-market sale Class A Common Stockindirect: By Brian J. G. Pereira 2012 Irrevocable Trust | -227,431 | $2.72 | $619k | 447,803 | Nov 14, 2025 |
| Nov 12, 2025 | Brian JG Pereira director | SOpen-market sale Class A Common Stockindirect: Brian J. G. Pereira 2004 Trust | -27,595 | $2.72 | $75k | 54,333 | Nov 14, 2025 |
| Nov 13, 2025 | Brian JG Pereira director | SOpen-market sale Class A Common Stockindirect: By Brian J. G. Pereira 2012 Irrevocable Trust | -447,803 | $2.37 | $1.1M | 0 | Nov 14, 2025 |
| Nov 13, 2025 | Brian JG Pereira director | SOpen-market sale Class A Common Stockindirect: Brian J. G. Pereira 2004 Trust | -54,333 | $2.37 | $129k | 0 | Nov 14, 2025 |
| Jul 8, 2025 | Darin J. Weber Chief Regulatory Officer | SOpen-market sale Class A Common Stock10b5-1 | -103,480 | $3.02 | $313k | 0 | Jul 9, 2025 |
| Jun 3, 2025 | Pablo G. Legorreta director, owner | CConversion Class A Ordinary Sharesindirect: See footnote | +3,823,996 | $0.00 | $0 | 26,441,905 | Jun 5, 2025 |
| Jun 3, 2025 | Pablo G. Legorreta director, owner | JOther Class A Ordinary Sharesindirect: See footnote | -3,823,996 | $0.00 | $0 | 22,617,909 | Jun 5, 2025 |
| Jun 3, 2025 | Pablo G. Legorreta director, owner | CConversion Class B Ordinary Sharesderivativeindirect: See footnote | -3,823,996 | $0.00 | $0 | 84,283,430 | Jun 5, 2025 |
| Jun 3, 2025 | Pablo G. Legorreta director, owner | CConversion Common Units in ProKidney LPderivativeindirect: See footnote | -3,823,996 | $0.00 | $0 | 84,283,430 | Jun 5, 2025 |
| May 29, 2025 | Uma Sinha director | AGrant or award Director stock option (right to buy)derivative | +125,862 | $0.00 | $0 | 125,862 | Jun 2, 2025 |
| May 29, 2025 | Brian JG Pereira director | AGrant or award Director stock option (right to buy)derivative | +125,862 | $0.00 | $0 | 125,862 | Jun 2, 2025 |
| May 29, 2025 | Santos Jose Ignacio Jimenez director | AGrant or award Director stock option (right to buy)derivative | +125,862 | $0.00 | $0 | 125,862 | Jun 2, 2025 |
| May 29, 2025 | Alan Lotvin director | AGrant or award Director stock option (right to buy)derivative | +125,862 | $0.00 | $0 | 125,862 | Jun 2, 2025 |
| May 29, 2025 | Pablo G. Legorreta director, owner | AGrant or award Director stock option (right to buy)derivative | +125,862 | $0.00 | $0 | 125,862 | Jun 2, 2025 |
| May 29, 2025 | Jennifer A. Fox director | AGrant or award Director stock option (right to buy)derivative | +125,862 | $0.00 | $0 | 125,862 | Jun 2, 2025 |
| May 29, 2025 | William F Doyle director | AGrant or award Director stock option (right to buy)derivative | +125,862 | $0.00 | $0 | 125,862 | Jun 2, 2025 |
| Apr 22, 2025 | Control Empresarial de Capitales S.A. de C.V. owner, other | POpen-market purchase Class A Ordinary Shares (as defined in Exhibit 99.1 hereto) | +387,393 | $0.71 | $276k | 73,842,723 | Apr 24, 2025 |
| Apr 17, 2025 | Control Empresarial de Capitales S.A. de C.V. owner, other | POpen-market purchase Class A Ordinary Shares (as defined in Exhibit 99.1 hereto) | +25,000 | $0.75 | $19k | 73,455,330 | Apr 21, 2025 |
| Apr 16, 2025 | Control Empresarial de Capitales S.A. de C.V. owner, other | POpen-market purchase Class A Ordinary Shares (as defined in Exhibit 99.1 hereto) | +100,000 | $0.75 | $75k | 73,430,330 | Apr 18, 2025 |
| Apr 14, 2025 | Control Empresarial de Capitales S.A. de C.V. owner, other | POpen-market purchase Class A Ordinary Shares (as defined in Exhibit 99.1 hereto) | +268,105 | $0.73 | $195k | 72,862,330 | Apr 16, 2025 |
| Apr 15, 2025 | Control Empresarial de Capitales S.A. de C.V. owner, other | POpen-market purchase Class A Ordinary Shares (as defined in Exhibit 99.1 hereto) | +468,000 | $0.70 | $326k | 73,330,330 | Apr 16, 2025 |
| Apr 10, 2025 | Control Empresarial de Capitales S.A. de C.V. owner, other | POpen-market purchase Class A Ordinary Shares (as defined in Exhibit 99.1 hereto) | +1,032,218 | $0.61 | $628k | 72,592,325 | Apr 14, 2025 |
| Apr 11, 2025 | Control Empresarial de Capitales S.A. de C.V. owner, other | POpen-market purchase Class A Ordinary Shares (as defined in Exhibit 99.1 hereto) | +1,900 | $0.61 | $1,155 | 72,594,225 | Apr 14, 2025 |
| Mar 1, 2025 | James Coulston Chief Financial Officer | AGrant or award Employee stock option (right to buy)derivative | +650,000 | $0.00 | $0 | 650,000 | Mar 4, 2025 |
| Mar 1, 2025 | Bruce Culleton Chief Executive Officer | AGrant or award Employee stock option (right to buy)derivative | +1,796,000 | $0.00 | $0 | 1,796,000 | Mar 4, 2025 |
| Mar 1, 2025 | Todd C Girolamo Chief Legal Officer | AGrant or award Employee stock option (right to buy)derivative | +650,000 | $0.00 | $0 | 650,000 | Mar 4, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Control Empresarial de Capitales S.A. de C.V.owner, other
- James CoulstonChief Financial Officer
- Bruce CulletonChief Executive Officer
- William F Doyledirector, chair, officer
- Jennifer A. Foxofficer, director
- Todd C GirolamoChief Legal Officer
- Santos Jose Ignacio Jimenezdirector
- Pablo G. Legorretaceo, chair, officer, director, owner
- Alan Lotvindirector
- Brian JG Pereiradirector
- Uma Sinhadirector
- Darin J. WeberChief Regulatory Officer
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.